Prof. Jean B. Nachega is a Professor of Medicine and Director of the Center for Infectious Diseases at Stellenbosch University Faculty of Health Sciences, Cape Town, South Africa. He is also an Associate Scientist, Department of International Health and Epidemiology at Johns Hopkins Bloomberg School of Public of Health, Baltimore, USA. He trained in Internal Medicine and Infectious Diseases at University of Louvain, Brussels, Belgium; then he completed a Diploma in Tropical Medicine and Masters of Public Health at the London School of Hygiene and Tropical Medicine and Johns Hopkins Bloomberg School of Public Health, respectively. Soon after receiving his PhD in Clinical Pharmacology in 2008 at University of Cape Town, he was awarded the John McGoldrick Fellowship in Biostatistics of AIDS Research at Harvard School of Public Health in 2009 under the supervision of Professor Steve Lagakos. Dr. Nachega has extensive clinical research experience in HIV and Tuberculosis in Africa with a goal of optimizing clinical and public health outcomes in HIV-infected adults. His research, teaching, and professional activities include planning, design, monitoring, and evaluation of clinical trials, cohort studies & programs for prevention and treatment of HIV/AIDS and tuberculosis in sub- Sahara Africa. With support of U.S. NIH/NIAID, the European and Developing Countries Clinical Trial Partnership (EDCTP) and the UK-based Wellcome Trust, he led or collaborated on various HIV and TB research programs. These training collaborations occurred in South Africa, Zambia, Namibia, Malawi, Uganda, Democratic Republic of the Congo and Botswana. Dr. Nachega is an ad hoc expert at World Health Organization within the HIV/AIDS Department HIV Treatment Guidelines Development Working Group as well as the HIV Drug Resistance group. He is also elected member of South African Academy of Sciences and serves as Principal Investigator of the US OGAC/PEPFAR Medical Education Partnership Initiative (MEPI) at Stellenbosch University Faculty Health Sciences in Cape Town.